Advanced Platinum-Resistant Ovarian Cancer
1 clinical trials · Condition
◉ Watch Advanced Platinum-Resistant Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors (NCT03861403) | Leap Therapeutics, Inc. | 2019-05-20 |
Track Advanced Platinum-Resistant Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.